Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Mesenchymal stem cells Potential treatment - clinical evidence Experimental Other treatment Oct/17/2022 63 3
Etesevimab Potential treatment - clinical evidence Experimental Antiviral Oct/15/2022 7 18
BRII-196 Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021 1 1
BRII-198 Potential treatment - theoretical effect Experimental Antiviral Dec/23/2021 0 2
C135 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021 2 0
COVA1-16 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021 3 0
mAb 2-36 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021 2 0
mAb 2-7 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021 2 0
Excel (.xslx) CSV (.csv)